Content about Pharmaceutical drug

March 31, 2014

The Food and Drug Administration on Friday approved over-the-counter Nexium 24HR (esomeprazole 20mg), Pfizer announced.

NEW YORK — The Food and Drug Administration on Friday approved over-the-counter Nexium 24HR (esomeprazole 20mg), Pfizer announced. 

“Switching medicines, whenever appropriate, from prescription to non-prescription status improves access, empowers consumers to care for their own health and is an important strategy for Pfizer,” stated Paul Sturman, president, Pfizer Consumer Healthcare. “The FDA approval of Nexium 24HR is a significant milestone in executing against our plan.”

March 27, 2014

Indiana Governor Mike Pence earlier this week signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines, according to published reports.

INDIANAPOLIS — Indiana Governor Mike Pence earlier this week signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines, according to published reports. 

The bill allows a pharmacist to substitute an interchangeable biosimilar product for a prescribed biological product if certain conditions are met. It requires the board of pharmacy to maintain a website that lists the biosimilar biological products that are determined to be interchangeable. 

The specific conditions include: 

March 20, 2014

AstraZeneca on Wednesday launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home.

WILMINGTON, Del. — AstraZeneca on Wednesday launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home. Nexium Direct is part of AstraZeneca Direct, a web-based offering that delivers select brand name prescription medications from AstraZeneca. The medications are dispensed by a team of registered pharmacists and certified pharmacy technicians available through a collaboration with Eagle Pharmacy.

March 13, 2014

More Americans are more often seeking their ounce of prevention. According to Bain & Co.’s recent Healthy Living Survey, 75% of consumers are in pursuit of a healthier lifestyle. Take that predominant mindset, coupled with the outcomes-driven preventive focus associated with the Affordable Care Act, and you have a formula for OTC success at retail pharmacy.

More Americans are more often seeking their ounce of prevention. According to Bain & Co.’s recent Healthy Living Survey, 75% of consumers are in pursuit of a healthier lifestyle. Take that predominant mindset, coupled with the outcomes-driven preventive focus associated with the Affordable Care Act, and you have a formula for OTC success at retail pharmacy.

To get a better sense of how OTC brands are helping to improve patient outcomes and drive down healthcare costs, DSN invited some leading OTC executives to share their opinions on the value of OTCs.

March 10, 2014

Two Rx-to-OTC switches in the past year may serve as a harbinger of what the Food and Drug Administration will consider “switch” worthy.

Two Rx-to-OTC switches in the past year may serve as a harbinger of what the Food and Drug Administration will consider “switch” worthy. They both address chronic care needs, and they both represent first of their kind medicines to the nonprescription aisle.

March 7, 2014

It's finally happening. Pfizer has placed the ball at the line of scrimmage. And based on the X's and O's to come out of its Lipitor OTC actual-use study, Pfizer will be making its run with its eye on the ultimate prize — a successful Rx-to-OTC switch of a statin.

Only this time, the Food and Drug Administration may not be as quick to sack Pfizer's switch attempt. With the advances and pervasion of health technology in the self-care space by way of smartphones and tablets; with the evolution of the pharmacist as a healthcare professional able to practice at the top of their license; and with the adoption of diagnostic tests like a cholesterol panel that can be physically administered in the pharmacy, consumers may finally get it right when self-selecting a statin.

Because it's the consumer actual-use studies that have scuttled just about every statin switch attempt in the past. In the last switch of Mevacor, FDA advisory panelists determined the statin was safe enough for the self-care space. And it was effective. It's just that the consumers who would be right for an OTC statin didn't appropriately self-select. And if they can't appropriately self-select, what's the point, really?

It's finally happening. Pfizer has placed the ball at the line of scrimmage. And based on the X's and O's to come out of its Lipitor OTC actual-use study, Pfizer will be making its run with its eye on the ultimate prize — a successful Rx-to-OTC switch of a statin. 

March 3, 2014

"The problem [of counterfeit medicines] is so big, disperse and complex that it requires a sweeping coordinated global response," wrote Scott LaGanga, executive director of the Partnership for Safe Medicines and SVP public affairs and advocacy for PhRMA in a blog published by The Hill on Saturday.

WASHINGTON — "The problem [of counterfeit medicines] is so big, disperse and complex that it requires a sweeping coordinated global response," wrote Scott LaGanga, executive director of the Partnership for Safe Medicines and SVP public affairs and advocacy for PhRMA in a blog published by The Hill on Saturday.

February 26, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday announced the appointment of Charles “Chuck” Clapton to the position of SVP federal advocacy, effective March 17, 2014.

WASHINGTON — The Pharmaceutical Research and Manufacturers of America on Tuesday announced the appointment of Charles “Chuck” Clapton to the position of SVP federal advocacy, effective March 17, 2014.  

In this capacity, Clapton will be responsible for leading PhRMA’s federal government affairs initiatives and advancing its legislative agenda, working with stakeholders to develop and advocate for health policies that foster innovation and ensure patient access to new medicines in the United States and around the world.  

February 25, 2014

UC-San Francisco and Walgreens on Tuesday opened a Walgreens store on the UCSF campus that aims to improve medication safety, decrease healthcare costs and help patients use medicines more effectively by offering pharmacist-based patient care and expanded health-and-wellness services to the community.

SAN FRANCISCO — UC-San Francisco and Walgreens on Tuesday opened a Walgreens store on the UCSF campus that aims to improve medication safety, decrease healthcare costs and help patients use medicines more effectively by offering pharmacist-based patient care and expanded health-and-wellness services to the community. A joint effort among Walgreens, the UCSF School of Pharmacy and UCSF Medical Center, “Walgreens at UCSF” also will explore new models for improving overall patient care.

February 7, 2014

In light of the evolving healthcare landscape, USA Today published an article on Friday about how pharmacists are increasingly working with doctors to assess patients, identify drug interactions and medication errors and, in some cases, even write a prescription.

The nation’s pharmacies are no longer just for prescription medications and states are proving to be the enablers to a broader the scope of practice.

In light of the evolving healthcare landscape, USA Today published an article on Friday about how pharmacists are increasingly working with doctors to assess patients, identify drug interactions and medication errors and, in some cases, even write a prescription.

January 28, 2014

In 2012, compounding made headlines when 64 people died as a result of fungal meningitis caused by contaminated compounded products.

In 2012, compounding made headlines when 64 people died as a result of fungal meningitis caused by contaminated compounded products.

History

January 21, 2014

The Consumer Healthcare Products Association responded to Sen. Charles Schumer’s, D-N.Y., recent call for the Food and Drug Administration and the Consumer Product Safety Commission to require flow restrictors on all bottles of children's liquid medicines.

WASHINGTON — The Consumer Healthcare Products Association on Monday responded to Sen. Charles Schumer’s, D-N.Y., recent call for the Food and Drug Administration and the Consumer Product Safety Commission to require flow restrictors on all bottles of children's liquid medicines.

January 9, 2014

Vulnerable patients, including seniors and cancer patients, suffer from lack of access to needed painkillers as efforts to combat diversion and misuse of controlled substances often result in drugs not getting into the hands of those who need them, according to a new pharmacist survey by the National Community Pharmacists Association.

ALEXANDRIA, Va. —Vulnerable patients, including seniors and cancer patients, suffer from lack of access to needed painkillers as efforts to combat diversion and misuse of controlled substances often result in drugs not getting into the hands of those who need them, according to a new pharmacist survey by the National Community Pharmacists Association. 

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

NEW YORK — News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds.

January 7, 2014

Ani Pharmaceuticals has bought 31 generic drugs from Teva Pharmaceuticals for $12.5 million, the company said.

BAUDETTE, Minn. — Ani Pharmaceuticals has bought 31 generic drugs from Teva Pharmaceuticals for $12.5 million, the company said.

January 7, 2014

Navarro Discount Pharmacy has been recognized as a winner of the 2013 UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.

MIAMI — Navarro Discount Pharmacy has been recognized as a winner of the 2013 UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.

Navarro was recognized in the small retail pharmacy chain and independent community pharmacy category for its ability to address gaps in medication adherence among a subgroup of UnitedHealthcare Medicare Advantage-Part D plan members.

January 6, 2014

Amneal Pharmaceuticals has launched an authorized generic version of a recently launched drug for gastroesophageal reflux disease, the company said.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched an authorized generic version of a recently launched drug for gastroesophageal reflux disease, the company said Monday.

January 6, 2014

VoicePort announced that they have launched their Medication Synchronization Program, SynchroScript, along with two of their other adherence services with Tops Friendly Markets Pharmacy, of Williamsville, N.Y.

ROCHESTER, N.Y. — VoicePort on Monday announced that they have launched their Medication Synchronization Program, SynchroScript, along with two of their other adherence services with Tops Friendly Markets Pharmacy, of Williamsville, N.Y. 

December 23, 2013

A federal court decision paves the way for Amneal Pharmaceuticals and its South Korean partnering company to market a drug for treating gastroesophageal reflux disease, the companies said Monday.

BRIDGEWATER, N.J. — A federal court decision paves the way for Amneal Pharmaceuticals and its South Korean partnering company to market a drug for treating gastroesophageal reflux disease, the companies said Monday.

December 17, 2013

Amneal Pharmaceuticals has launched a new treatment for gastroesophageal reflux disease under a partnership with a South Korean drug maker.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched a new treatment for gastroesophageal reflux disease under a partnership with a South Korean drug maker.

Amneal announced Tuesday the launch of esomeprazole strontium delayed-release capsules in the 49.3-mg strength, which it is marketing in the United States under a contract with Hanmi Pharmaceutical Co. The drug is expected to begin shipping Wednesday in 30-count bottles.

December 13, 2013

Navarro Discount Pharmacy, which operates 33 locations in Southern Florida, has introduced a compliance packaging program, EZ Meds Medicine Packaging System, that organizes a patient’s prescription medications into individual packets with labels and instructions.

MIAMI, Fla. — Navarro Discount Pharmacy, which operates 33 locations in Southern Florida, has introduced a compliance packaging program, EZ Meds Medicine Packaging System, that organizes a patient’s prescription medications into individual packets with labels and instructions.

December 12, 2013

The National Community Pharmacists Association urged U.S. Senators on the Senate Finance Committee to support a proposal intended to expand coverage in the Medicare Part D prescription drug program of medication therapy management programs.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday urged U.S. Senators on the Senate Finance Committee to support a proposal — scheduled for a vote as soon as Thursday — intended to expand coverage in the Medicare Part D prescription drug program of medication therapy management programs.

December 6, 2013

A study conducted among rural patients at Thrifty White Pharmacy locations in the Midwest and published in the November/December issue of the Journal of the American Pharmacists Association found that patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't receive them.

Over the years, study after study has shown that pharmacists can play a crucial role in ensuring that patients take their drugs when they're supposed to and as instructed. And poor medication adherence is no small issue, as studies have shown it costs the country nearly $300 billion per year, in addition to contributing to poor health outcomes. It's been said that improvements in medication adherence can be the equivalent of a blockbuster drug, and according to the National Coalition on Health Care, self-management of chronic diseases could save $10 for every $1 spent.

A study conducted among rural patients at Thrifty White Pharmacy locations in the Midwest and published in the November/December issue of the Journal of the American Pharmacists Association found that patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't receive them.

December 2, 2013

Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

WASHINGTON — Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

November 22, 2013

On Nov. 18, the Senate passed by voice vote the Drug Quality and Security Act, sending to president Barack Obama's desk legislation that implements federal tracking and tracing of drugs and strengthens federal regulations on pharmacy compounding.

The bipartisan bill, which has the support of such trade groups as the National Association of Chain Drug Stores, the National Community Pharmacists Association and the Generic Pharmaceutical Association, ties up a couple of problematic loose ends in the pharmaceutical supply chain, namely the so-called "downstream" supply chain, which refers to the path that drugs take from their manufacturers to providers and patients, as well as sterile compounding.

On Nov. 18, the Senate passed by voice vote the Drug Quality and Security Act, sending to president Barack Obama's desk legislation that implements federal tracking and tracing of drugs and strengthens federal regulations on pharmacy compounding.